Medicare Enrolled

Dr. Lindsay Ledwich, DO

Rheumatology · Pittsburgh, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1 ROBINSON PLZ STE 230, Pittsburgh, PA 15205
4127305540
In practice since 2007 (19 years)
NPI: 1124227103 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ledwich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ledwich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ledwich

Dr. Lindsay Ledwich is a rheumatology specialist in Pittsburgh, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ledwich performed 181 Medicare services across 122 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ledwich received a total of $52,191 from 58 pharmaceutical and/or device companies across 1951 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ledwich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 181 Medicare services $52,191 industry payments

Medicare Practice Summary

Medicare Utilization ↗
181
Medicare services
Bottom 22% in PA for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
122
Unique beneficiaries
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
91 $121 $295
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $84 $210
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
17 $92 $210
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
16 $25 $45
New patient office visit, complex (60-74 min) 11 $149 $365
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$52,191
Total received (2018-2024)
Avg $7,456/year across 7 years
Top 11% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
1,951
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,370 (50.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,341 (44.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,480 (4.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,845
2023
$2,585
2022
$3,932
2021
$6,170
2020
$7,131
2019
$15,128
2018
$15,400

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$409
ABBVIE INC.
$274
Janssen Biotech, Inc.
$260
PFIZER INC.
$155
Aurinia Pharma U.S., Inc.
$131
UCB, Inc.
$115
ANI Pharmaceuticals, Inc.
$95
Fresenius Kabi USA, LLC
$91
SOBI, INC
$48
Novartis Pharmaceuticals Corporation
$46
GlaxoSmithKline, LLC.
$45
Mallinckrodt Hospital Products Inc.
$40
Sandoz Inc.
$40
E.R. Squibb & Sons, L.L.C.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Actelion Pharmaceuticals US, Inc.
$20
Lilly USA, LLC
$16
Top 3 companies account for 51.1% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie, Inc.
$10,433
Horizon Therapeutics plc
$7,260
Horizon Pharma plc
$6,012
Janssen Biotech, Inc.
$4,706
Amgen Inc.
$3,946
PFIZER INC.
$2,353
UCB, Inc.
$2,144
Novartis Pharmaceuticals Corporation
$1,865
GlaxoSmithKline, LLC.
$1,183
Lilly USA, LLC
$1,103
Daiichi Sankyo Inc.
$1,086
ABBVIE INC.
$1,078
AbbVie Inc.
$1,039
Genentech USA, Inc.
$875
E.R. Squibb & Sons, L.L.C.
$773
Mallinckrodt Hospital Products Inc.
$628
Radius Health, Inc.
$509
Antares Pharma, Inc.
$377
Regeneron Healthcare Solutions, Inc.
$370
Ferring Pharmaceuticals Inc.
$356
Aurinia Pharma U.S., Inc.
$318
Mallinckrodt Enterprises LLC
$295
AstraZeneca Pharmaceuticals LP
$269
ANI Pharmaceuticals, Inc.
$243
Collegium Pharmaceutical, Inc.
$229
Mallinckrodt LLC
$187
Celgene Corporation
$182
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$157
Alexion Pharmaceuticals, Inc.
$155
Bioventus LLC
$145
Flexion Therapeutics, Inc.
$144
Hikma Pharmaceuticals USA
$138
MEDAC PHARMA, INC.
$136
Sobi, Inc
$131
Fresenius Kabi USA, LLC
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$128
GENZYME CORPORATION
$127
SOBI, INC
$126
Exeltis, USA Inc.
$120
Takeda Pharmaceuticals U.S.A., Inc.
$118
MEDEXUS PHARMA, INC.
$102
Sandoz Inc.
$77
Purdue Pharma L.P.
$67
Kaleo, Inc.
$44
Ultragenyx Pharmaceutical Inc.
$43
Shire North American Group Inc
$43
Actelion Pharmaceuticals US, Inc.
$43
Sebela Pharmaceuticals Inc.
$33
Teva Pharmaceuticals USA, Inc.
$25
SCILEX PHARMACEUTICALS INC.
$23
BioDelivery Sciences International, Inc.
$23
Eisai Inc.
$21
Alfasigma USA, Inc.
$14
Oxford Immunotec USA Inc
$14
Mission Pharmacal Company
$13
Ethicon US, LLC
$12
TerSera Therapeutics LLC
$11
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 45.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AVSOLA · Actemra · Amitiza · Aquoral · BENLYSTA · BUNAVAIL 2.1 mg 30-count box · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · Dayvigo · Durolane · EUFLEXXA · EVENITY · EVZIO · Enbrel · Evzio · FORTEO · HUMIRA · HYQVIA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · INJECTAFER · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LINX Reflux Management System · LUPKYNIS · LYRICA · Mitigare · Morphabond ER · Movantik · NO_PRODUCT · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · ORENCIA · OTREXUP · OXYCONTIN · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · RELISTOR · REMICADE · RENFLEXIS · RIDAURA · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SYMPROIC · Strensiq · TALTZ · TAVNEOS · TREMFYA · TSPOT TB TEST · Tavneos · Tymlos · UBRELVY · Uloric · XELJANZ · XTAMPZA · XYOSTED · Xolair · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a rheumatology specialist in Pittsburgh?
Compare rheumatologists in the Pittsburgh area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
64
Per 100K population
5.2
County median income
$76,393
Nearest hospital
ST CLAIR HOSPITAL
4.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ledwich is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ledwich experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Ledwich performed 91 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ledwich receive payments from pharmaceutical companies?
Yes. Dr. Ledwich received a total of $52,191 from 58 companies across 1,951 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ledwich's costs compare to other rheumatologists in Pittsburgh?
Dr. Ledwich's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ledwich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →